Press Releases Year: - Any -2024202320222021202020192018201720162015201420132012 Date Title and Summary Additional Formats Toggle SummaryJun 21, 2012 Agile Therapeutics to Present at the 12th European Society of Contraception and Reproductive Health Congress Toggle SummaryJul 3, 2012 Agile Therapeutics Announces FDA Accepts New Drug Application for its Low-Dose, Once-Weekly Contraceptive Patch Toggle SummaryJul 12, 2012 Agile Therapeutics to Present at OneMedForum New York 2012 Toggle SummaryAug 1, 2012 Agile Therapeutics Chief Medical Officer Dr. Marie Foegh Selected as one of Top 100 Healthcare Leaders by PharmaVOICE Toggle SummaryAug 27, 2012 Agile Therapeutics Announces Three New U.S. Patents on Its Technology and the Brand Name Twirla™ for Its First Contraceptive Patch Toggle SummarySep 20, 2012 Agile Therapeutics to Present at CBI’s Forum on Phase II-III Clinical Study Optimization Toggle SummarySep 24, 2012 Phase III Data Show Agile Therapeutics’ Contraceptive Patch had Greater Compliance than an Oral Contraceptive Toggle SummaryOct 16, 2012 Agile Therapeutics Commercial Head to Present at Digital Pharma East Toggle SummaryNov 1, 2012 Phase III Data Show Greater Compliance Across Demographic Groups With Agile Therapeutics' Contraceptive Patch Compared to an Oral Contraceptive Toggle SummaryNov 14, 2012 Agile Therapeutics Commercial Head Named Bronze Stevie Winner in the 2012 Stevie® Awards for Women in Business Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last